English
Polski
Español
українська
Levothyroxine in newly pregnant TPOAb-positive euthyroid women
Does levothyroxine therapy reduce the risk of pregnancy loss in thyroid peroxidase antibody (TPOAb)-positive euthyroid women who are newly pregnant?
2020-11-13
Does levothyroxine therapy reduce the risk of pregnancy loss in thyroid peroxidase antibody (TPOAb)-positive euthyroid women who are newly pregnant?
What is the appropriate treatment in patients with severe hypothyroidism and myxedema coma? What thyroid hormones should be administered (T4 and T3 administered together or separately)? What dosing should be used?
What are the key diagnostic criteria for myxedema coma? What signs and symptoms are the most alarming?
What is the most important change in the management of type 2 diabetes according to the 2018 consensus report by the American Diabetes Association (ADA) and the European Association of the Study of Diabetes (EASD)?
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors increase renal glucose excretion. Can they be used in older patients with diabetes who often have bacterial colonization but no urinary tract infections?
What are the treatment options for inhibiting the synthesis and secretion of new hormones in severe hyperthyroidism? How much time is needed to see clinical outcomes?
Why is the Burch-Wartofsky Point Scale based only on clinical and physical criteria? How accurate are the estimates?
What are the key diagnostic criteria for thyroid storm? What signs and symptoms are the most alarming and require immediate medical attention?
Should patients with thyroid emergencies (myxedema coma, thyroid storm) be treated in the intensive care unit (ICU)? What parameters and laboratory tests should be monitored?
